[go: up one dir, main page]

GB201904160D0 - Cell - Google Patents

Cell

Info

Publication number
GB201904160D0
GB201904160D0 GBGB1904160.7A GB201904160A GB201904160D0 GB 201904160 D0 GB201904160 D0 GB 201904160D0 GB 201904160 A GB201904160 A GB 201904160A GB 201904160 D0 GB201904160 D0 GB 201904160D0
Authority
GB
United Kingdom
Prior art keywords
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1904160.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autolus Ltd
Original Assignee
Autolus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autolus Ltd filed Critical Autolus Ltd
Priority to GBGB1904160.7A priority Critical patent/GB201904160D0/en
Publication of GB201904160D0 publication Critical patent/GB201904160D0/en
Priority to EP19824193.7A priority patent/EP3893923A2/en
Priority to PCT/GB2019/053538 priority patent/WO2020120982A2/en
Priority to US17/312,755 priority patent/US20220056407A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
GBGB1904160.7A 2018-12-14 2019-03-26 Cell Ceased GB201904160D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB1904160.7A GB201904160D0 (en) 2019-03-26 2019-03-26 Cell
EP19824193.7A EP3893923A2 (en) 2018-12-14 2019-12-13 Cell
PCT/GB2019/053538 WO2020120982A2 (en) 2018-12-14 2019-12-13 Cell
US17/312,755 US20220056407A1 (en) 2018-12-14 2019-12-13 Cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1904160.7A GB201904160D0 (en) 2019-03-26 2019-03-26 Cell

Publications (1)

Publication Number Publication Date
GB201904160D0 true GB201904160D0 (en) 2019-05-08

Family

ID=66218273

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1904160.7A Ceased GB201904160D0 (en) 2018-12-14 2019-03-26 Cell

Country Status (1)

Country Link
GB (1) GB201904160D0 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052906B1 (en) 1999-04-16 2006-05-30 Celltech R & D Limited Synthetic transmembrane components
WO2015052538A1 (en) 2013-10-10 2015-04-16 Ucl Business Plc Chimeric antigen receptor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052906B1 (en) 1999-04-16 2006-05-30 Celltech R & D Limited Synthetic transmembrane components
WO2015052538A1 (en) 2013-10-10 2015-04-16 Ucl Business Plc Chimeric antigen receptor

Non-Patent Citations (24)

* Cited by examiner, † Cited by third party
Title
"UniProtKB", Database accession no. 014494
"UniProtKB", Database accession no. 014495
"UniProtKB", Database accession no. 095470
"UniProtKB", Database accession no. A8K563
"UniProtKB", Database accession no. B3KV62
"UniProtKB", Database accession no. P00813
"UniProtKB", Database accession no. P05089
"UniProtKB", Database accession no. P13254
"UniProtKB", Database accession no. P14679
"UniProtKB", Database accession no. P15428
"UniProtKB", Database accession no. P20132
"UniProtKB", Database accession no. P20711
"UniProtKB", Database accession no. P21589
"UniProtKB", Database accession no. P23793
"UniProtKB", Database accession no. P35510
"UniProtKB", Database accession no. P54687
"UniProtKB", Database accession no. P60568
"UniProtKB", Database accession no. Q01432
"UniProtKB", Database accession no. Q16719
"UniProtKB", Database accession no. Q60030
"UniProtKB", Database accession no. Q8K3F7
"UniProtKB", Database accession no. Q9SI64
"UniProtKB", Database accession no. Q9ULC6
DONNELLY ET AL., J. GEN. VIROL., vol. 82, 2001, pages 1027 - 1041

Similar Documents

Publication Publication Date Title
CA186123S (en) Battery
GB201813178D0 (en) Cell
PL3930031T3 (en) Battery
GB201819540D0 (en) T cell modification
IL288221A (en) Safe immuno-stealth cells
GB201716728D0 (en) Cell
GB201714718D0 (en) Cell
GB201803079D0 (en) Cell
PL3836300T3 (en) Battery
GB201707779D0 (en) Cell
GB201720949D0 (en) Cell
GB201707783D0 (en) Cell
GB201904971D0 (en) Cell
HUE061671T2 (en) Secondary cell
GB201718697D0 (en) Cell
GB201816399D0 (en) Cell
GB201807693D0 (en) Cell
GB201915526D0 (en) Modified cell
GB201906202D0 (en) Cell
GB201805918D0 (en) Cell
GB2574854B (en) Cell selection procedures
CA190719S (en) Battery
GB201820463D0 (en) Electrochemical sythenesis
GB201919017D0 (en) Cell
GB201918906D0 (en) Cell

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)